To the Editor, Low bone mineral density (BMD) is emerging as an important cause of morbidity and disability in the adults with transfusion dependent thalassemia [1] . There is lack of data in patients from India [2, 3] . We assessed bone mineral density in patients attending our thalassemia day care center. Forty patients largely from lower and middle income groups were recruited, of which 26 were male. The median age of the study cohort was 19.5 years (15-38 years). The mean weight was 44 ± 10.3 kg and mean height was 152.5 ± 12 cm. Pain was evaluated using a Quadruple visual analog scale. BMD was measured in all patients by a dual energy X-ray absorptiometry (DXA) densitometer (Hologic, Bedford, MA, USA) at the lumbar spine (L1-L4), left hip and left forearm. Adults were stratified based on BMD expressed as T-score, i.e., normal, osteopenic (between -1 and -2.5 SD) and osteoporotic patients (below -2.5 SD). Z score less than -2 were used to classify low BMD in patients less than 20 years.
Hormonal levels were assessed in 32 patients and 12 (37.5%) patients showed evidence of hypogonadism. Eight patients (25%) were hypothyroid. Three patients (7.5%) were HbsAg positive. Twenty-three (57.5%) patients had anti HCV antibody positive and 3 patients (7.5%) were HIV positive. HCV RNA was not measured. All patients were receiving iron chelation in the form of deferiprone. Six patients were also receiving desferroxamine infusion. The iron chelation was irregular in most patients as reflected by the mean serum ferritin levels of 4141 ± 2275 ng/ml. Mean serum calcium, phosphate and alkaline phosphatase levels were 8.7 ± 0.8 mg/dl, 5.4 ± 1.8 mg/dl and 257 ± 183 IU respectively. Seven (17.5%) patients complained of bone pain. Pain scores of 1, 3, 4 and 5 were reported by 1, 2, 3 and 1 patient respectively. The Pain score did not correlate with any of the evaluated study variables. There were ten fractures in 7 patients (17.5%) at different sites on review of their history. Six patients had history of fractures while one patient developed a fracture during the study period. Fractures in most of the patients were associated with some form of trauma. Moreover, three patients had 2 episodes of fractures. Six patients with fracture had osteoporosis. No study parameter correlated with the fracture risk. Table 1 shows the fracture sites in the study patients.
In children less than 20 years age, fifteen patients (75%) had low bone mineral density ( Table 2 ). The BMD at forearm was significantly lower in patients with hypogonadism (p = 0.022), smaller height (p = 0.028) and weight (p = 0.025). Hypogonadism was negatively associated with low BMD at hip (p = 0.093).
Mean age in patients more than 20 years is 22.8 ± 4.5 years. There were 11 females. Five (25%) patients had hypogonadism. Twelve patients (60%) were seropositive for hepatitis C. Seventeen patients (85%) had osteoporosis and 3 patients (15%) had osteopenia. The BMD at lumbar region (p = 0.039) and hip region (p = 0.043) was lower in hypogonad patients. Hepatitis C infection was associated with lower z scores at hip (p = 0.029) and lower T scores at forearm (p = 0.047). There were no differences in BMD between men and women, and did not correlate with iron overload.
During the last decade, the presence of osteopenia or osteoporosis in well-treated thalassemia major (TM) patients has been described in different studies with a frequency of approximately 40-50% in the studied populations [1, 2] . Young age in our cohort suggests that bone health starts to suffer early in life. Merchant et al. [3] have documented an incidence of 81% osteoporosis in children from western Indian center.
We did not observe a correlation between low bone mass and low Hb level in our thalassemic patients. We have not measured vitamin D levels and it is known that vitamin D deficiency can result in low bone mineral density. Hypogonadism is a well-recognized cause of osteoporosis and osteopenia. However, despite hormonal replacement, calcium and vitamin D administration, effective iron chelation, and normalization of hemoglobin levels, patients with TM continue to lose bone mass [4, 5] .
The North American Thalassemia Clinical Research Network database registry noted an overall fracture prevalence amongst all thalassemia syndromes of 12.1%. Prevalence increased with age and with use of sex hormone replacement therapy. Presence of endocrinopathies anthropometric parameters, heart disease or hepatitis C was not significant independent predictors of fractures [5] .
It would have been ideal if we could perform proper hormonal assessment in all children and everyone was chelated properly. Nonetheless, this study points out poor bone health and fracture risk in Indian patients with transfusion dependent thalassemia. NA not available
